Ketone ester supplementation in Angelman syndrome mouse models improves multiple disease phenotypes including motor coordination, learning and memory, and seizure threshold, while increasing the GABA/glutamate ratio in the hippocampus, suggesting a potential therapeutic approach for this genetic disorder.
Ketone Ester Treats Angelman Syndrome Seizures in Mouse Model
Added:[Music] um okay well I'd like to thank you all for coming to my talk uh especially the last presentation before lunch I know that's rough uh so I'm going to go ahead and get started I'm not sure if he mentioned the title but it's a project involving treatment of an Angelman syndrome Mouse model with the Ketone Nester so first of all I wanted to focus why specifically um we F can you hear me people look like they yeah okay why we decided to specifically focus on the treatment of Angelman syndrome it's a rare neurological disorder with a prevalence of about 1 in 15 to 1 in 20,000 and first Angelman syndrome is involved it's a monogenic disorder it's involving a single housekeeping Gene ube3a which is an E3 bod and ligase and somehow this is causing many of the neurological defects that we see in angel menome patients such as developmental delay speech impairment Motor problems such as a taxia or trimor seizures and a characteristic abnormal EEG secondly as is considered to be a disorder of epilepsy with greater than 80% of individuals with as being diagnosed with seizures lastly Angelman syndrome is a relatively new disorder at least in the realm of research while it was first described by Dr Harry Angelman in 1965 it it wasn't until 1998 that the first Mouse model was created and so it's been 18 years where a lot of research has been done and we have progressed pretty well however there is still no cure for this disorder so I want to focus a little bit more about specifically uh epilepsy in as like I mentioned previously greater than 80% of individuals with as are diagnosed with seizures and typically they're diagnosed within their first year of Life typically having over 100 seizures per day and at least by age three almost all of them are diagnosed with seizures unfortunately they're commonly admitted to the hospital due to being in status and sadly seizures are a common cause of death in this patient population I've listed many of the common seizure types here but there are a few more but however the origin of seizures in as is currently unknown additionally intractable epilepsies very common in as um they are refractory to many medications and unfortunately this has been linked to both hipocampal damage hipocampal damage sorry and cognitive decline if not well controlled I would consider some of the current treatments and aeds today to be ineffective simply because there are so many intractable cases in as specifically and additionally these ads have a lot of cognitive and motor related side effects Which is less than ideal in a patient population that already has severe cognitive and motor related issues so I'm going to go into just a little bit of detail about the ASM model that I used for this study um this was again the one that was created in 1998 it's a null mutation model that that inactivates all ube3a isoforms the mouse does recapitulate the phenotypes seen in hum with as pretty well they have a audiogenic seizure phenotype they also with like with the adenosine receptor mice they also have when you look at eegs they have spontaneous seizures even though you do not see behavioral seizures there are also learning and memory deficits synaptic plasticity deficits and U motor impairment problems and this can be seen throughout a vast array of Behavioral testing um some of which I've listed here so I would like to discuss with you just a little bit about differences in strain simply because I did use two different strains in the study first the c-57 black 6 strain which is very well characterized and is capable of complex learning over multiple tasks so this was primarily for a lot of Behavioral testing while the 129 animals had the inducible audiogenic seizure phenotype but they don't perform as well on those tests so I know this is a lot of text but I'm going to go through it all um this is is some of the recent research that's showing an excitatory inhibitory imbalance in the as brain this could be a reason why there's overall hyper excitability in the brain and could be tied to the seizure aspect first uh it was seen in the cortex in the L2 L3 cortical paramal neurons specifically that there was a decrease in inhibitory or in excitatory inputs but a resulting more significant decrease in inhibitory dve onto these neurons so this created this excitatory inhibitory imbalance and an overall increased excitation or decrease in inhibition so this can lead to a decreased signal to noise ratio which can obviously affect detection and integration of sensory information moving into another region of the as brain or the as Mouse brain was the cerebellum they noted a group noted 160 Hertz fast oscillations in the cerebellum and you typically see about 30 to 80 another group saw decreased tonic inhibition in cerebell granual cells this same group saw increases in gap one a Gaba transporter suggesting there be decreased Gaba in the area so what they did was administer a Gaba Agonist called thip IP to the mice and they did see that they that improved abnormal pingi cell firing and also significantly improved the axic phenotype seen in the as mice moving into the human as brain uh it was reported in a case study in 1991 that there was a decrease in cerebel or Gaba and an increase in cortical glutamate again all of us tying into that idea of an excitatory inhibitory imbalance potentially so The Next Step was to look at novel as Therapeutics potentially with fewer side effects that could increase tonic inhibition by increasing things like the gab glutamate Ratio or just by increasing overall gab argic output so many of you have seen this and I know there are lots of potential anti-com Volson mechanisms of the diet we know that definitely but just for the purposes of this project I wanted to focus on one specific aspect being the increased gabic output and so um as we know Ketone bodies can come can generate acetyl COA which enters the TCA cycle by this synth pathway which uses a lot of oxelo acetate and makes it less available trans amination ofate to aspartate the IDE here is that potentially there could be more glate available for the synthesis of Gaba um bya glutamic acid decarboxylase additionally Ketone bodies and asites would results in production of glutamine and that's also an important precursor for Gaba so looking specifically at the ketogenic diet and the use of the ketogenic diet in Angelman syndrome there was a review that reported 100% success in children for children ages 5 to8 but there weren't really many details just saying they reduced their aeds and they had it had anti-convulsant activity but there were two reported case studies one was an 18-month-old and the second was a 5-year-old both with intractable seizures they were refractory to at least three aeds and the 18th month-old was having hundreds of seizures a day the 5-year-old what was really interesting after initiation of the ketogenic diet within two days they were completely seizure free and so they ended up doing a long-term study with the 5-year-old um and they this 5-year-old was ultimately reduced to one AED in the ketogenic diet and this is just an example of the um eegs of this 5-year-old before ketogenic diet initiation and two years following and you can see a lot of the epileptiform activity in slow wave complexes in a more normalized EEG two years following that ketogenic diet and this chart was provided to me by Dr Douglas nordley he's a neurologist in Chicago who comes into contact with this patient population very frequently so this has just been his personal experience with the various seizure types seen in as and potential seizure treatments and I really just wanted to focus on two things here the ones that seem to be the most effective against the most seizure types the ketogenic diet and valproate and again you can see most effective um again we were trying to look for something that potentially wouldn't have the same type of side effects as Val Pro but unfortunately with the ketogenic diet um individuals with as have GI issues sometimes they have trou they have difficulty gaining weight and lastly they often have sensory issues so they're sensitive to smell taste so they can be pretty picky eaters so we wanted to define something that mimic the ketogenic diet um potentially having neuroprotective effects but we could just add it to their standard diet without ultimately affecting their overall dietary intake so we decided to utilize a ketone Esther that was provided to us by Dr gustino um this was the rs13 butane dial dieto acetate Esther and it has been shown to induce therapedic ketosis in both dogs and pigs and has signif significantly delayed CNS oxygen toxicity seizures so the hypothesis here was that this Ketone Esther would positively affect a lot of the phenotypes in the as Mouse model including decreasing sign seizure frequency and increasing the latency to seize potentially improving learning in memory in the motor impairments and synaptic plasticity in the as Mouse model so what we did was we provided the Ketone Ester administered the Ketone Ester at 10% of the total volume of their standard Tech diet we wanted to get to 30 to 40% that was the goal but in pilot studies with the more sensitive 129 animals we started with 10 and 20% and they did not tolerate the 20% diet very well um it's a different story for the c57s but just for consistency's sake we stuck with the 10% total volume um we fed them at lium for 8 weeks and took blood from the tip of the tail one time per week for both beta hydroxy butter and glucose measurements anytime you're going to see this data um there's typically about 8 to 12 animals per group and they were two to three months of age so these were adult mice We performed behavioral testing seizure testing and this included the induced audiogenic seizures we administered 115 dbel white noise um until they seiz or for a maximum of 60 seconds and we also administered canic acid at 20 milligrams per per kilogram for chemically induced seizures as well we performed hippoc hippoc cample electrophysiological testing specifically ltp and also performed metabolic analyses so starting with the 129 data first what you're looking at here is open field and elevated plus um you're looking at wall type as non-treated wall type treated and as cre and just this there are no differences between groups and this is just suggesting no differences in general locomot activity or anxiety which is not going to negatively affect any behaviors that you'll see next so we wanted to focus on um a memory task and this was object recognition memory and a wild type animal is typically going to want to explore a novel object compared to an old object more often and so what you see here is exploratory preference and 50% is considered chance so these animals here are all with the novel object so you see a deficit in exploratory preference with the as animals with a significant Improvement or increase in exp and exploration the novel object with as treated animals suggested suggesting enhanced object recognition memory and this is just another way of showing the data but you can see how much time they spent with the old object compared to a novel object it's just a ratio and anything below zero means they actually spent more time with the old object so not only are they spending less time with the novel they're spending a little bit more time with the old while all of these animals spending more time with the new object so moving into more motor related data and a toxic phenotype first we looked at the rotor rod and this is an accelerated rotor Rod um it accelerates from 4 to 40 RPMs over the course of 5 minutes and what we look at is the latency to fall off the rod so you see Wild tape animals are here and as animals are here and they have a significant uh decrease in latency to fall off the rod and we see a significant improvement in our as treated animals suggesting improvements in motor coordination so we want to explore the motor phenotype a little bit more thoroughly and look at something that tests Subacute muscle function or fatigue and this is the wire hang task and so this is where you have a thin wire place the animals with their two front PS on the wire and let them hang on until they fall off or for a maximum of 60 seconds and what we saw here again was a significant decrease in the latency to fall in our as animals with a significant Improvement to or increased latency to fall in our as treated animals comparable to Wild type and lastly what we wanted to look at was the hin Lim clasping reflex and this is uh something we typically see a higher score in our as animals and is just a uh measure of neurologic function and you typically also see a higher score in mice with cerebella at taxus so what we do here is lower the Animal by its tail for 10 seconds and what you do is look for a score from 0 to three and what you see in Wild type animals are the highins consistently spayed outward away from the abdomen and this is an example of the wild type type animal a score of one is where one hind limb is retracted toward the abdomen a two both hind limbs are partially retracted towards the abdomen and three both High limbs are entirely retracted touching the abdomen and typically in this clasping form and what we saw was a significant improvement in our as treated animals in this High Li clasic score again all this suggesting an overall motor Improvement so next we looked at synaptic plasticity and what our lab and Dr Weber has seen previously is a deficit following Theta bir stimulation in ltp in our as animals compared to Wild type and what we saw was enhanced ltp or at least rather not as significantly impaired ltp compared to as animals and this is without changes in basil synaptic transmission or short short term synaptic plasticity so this was very interesting to see a normalization or a change in synaptic function so moving into the seizure data I wanted to let you know how we actually scored the canic acid seizures we used a modified rine scale going from stage zero to Stage seven so you go through things like immobility repetitive movements like head bobbing rearing and falling which is an example of the mice doing so here rearing on their High Limbs and falling over um there can also be continuous rearing and falling and then they can lose posture and have severe whole body convulsions and sometimes death so starting with the audiogenic seizure data what we saw was a decrease in just the overall seizure frequency and then an increase or significant increase in the as treated animals and the latency to Seas again suggesting we somehow affecting overall inhibition and improving um the seizure phenotype for canic acid seizures we didn't see uh consistency throughout the entire test but we did see a delay in the severity of the onset of canic acid seizures again Were Somehow affecting inhibition and again all of us showing this is potentially anti-convulsant in Ras Mouse model and this was just to show wild type and as treated animals at Baseline Week 1 and week eight just throughout the course of the study that there were significant increases in beta hydroxy beate suggesting our Ketone Esther is working as expected so then moving on into the c-57 data and these are not the seizure prone animals uh looking at the group weights typically the c57s as animals are actually overweight which some of the as children are as well and we actually sell a normalization of weight in our as treated animals and again similar to what we saw in the 129s significant increases in beta hydroxy butter rate throughout the course of the study so here looking at open field again no General differences in locomotive activity and what we saw was with the wire hang task we saw a trend towards Improvement in Subacute muscle function but not a significant change like we saw in the 129 animals and this is just an example of wild type animals performing the task they can actually pull up and are strong enough to pull and hold on with all four limbs while this is the as animal that struggles quite a bit so looking at the high Lim class being score we again saw a significant Improvement a decrease inre in the classing score in the as treated animals and in the rotor Rod throughout the course of the test we saw a significant increase in latency to fall in as treated animals like we saw at the 129s suggesting increases or improvements in both motor coordination and motor learning but this was not as drastic as what we saw in the 129s if you remember again though this is still suggesting overall improvements in both motor and neurologic function so then moving into uh a memory task in the c57 animals so what we looked at was itive learning or a fear conditioning Paradigm and this was using a condition unconditioned stimulus this was the tone foot shock two foot shock Paradigm and we looking at as percent freezing and this is to see ultimately if they will end up remembering um the the stimulus the stimulus so at the first day they both the all groups train to the same extent and 24 hours later you put them in the same context to see if they remembered and look at their percent freezing we saw a significant decrease in percent freezing in our as animals with a significant Improvement comparable to Wild type in our as treated animals and this is hipocampal dependent while cued Fe conditioning you put them in a different context and you have them in there for 3 minutes with no tone and 3 minutes with the tone and we typically don't see deficits in our as treat animals and we saw no differences in freezing throughout all of the groups but again all of this suggests improvements in associative learning so I know there's a lot of data to throw at you so I just wanted to show a summary and point out a couple important things and consistencies between the two strains improvements in learning and memory tasks and improvements in um significant motor improvements over multiple tasks this is very important for the this patient population who often they can't even walk so um I just wanted to point that out so then moving into the metabolic analyses so we looked in the plasma um for at both we looked for both betah hydroxy berate and aceto acetate seeing increases in both uh the wild type and as treated animals and then what we wanted to look at was the Gaba glutamate r ratio and we specifically looked in the hippocampus and stalked significant increases in our as treated animals um compared to as non-treated so this is suggesting we're increasing tonic inhibition and if you look really closely you'll see that there's a difference but very similar results in our c57 animals in the hippocampus increased bet hydroxy butter and acetoacetate in the plasma and a significant increase in the gapit glutamate ratio and this is just uh data that's it's been suggested that obviously if you're increasing but potentially you should be in increasing glutamic acid DEC carboxilate potentially so I looked at both Gad 65 and 67 in the hippocampus and the cerebellum and either saw Trends or significant increases in both Gad 65 and 67 in both the cerebellum and hip the campus so in summary over eight weeks of Ketone Esther treatment we saw increased beta hydroxy berate levels throughout treatment suggesting the Ketone Esther was working as expected it was anti-com in our Mouse model normalized weights in c57 R c57 mice we saw motor improvements as could see by the rotor rod wire hang and clasping score we saw memory improvements in the object recognition and associative memory tasks and also enhanced synaptic plasticity for the metabolic analyses we saw both increase beta hydroxy berate and acetoacetate in the plasma and an overall increase in the gabit glate ratio in hippocampus so for the next step we would like to perform more extensive metabolic analyses look at TCA cycle intermediates and a few other things and we'd also like to increase the uh total volume of the diet especially for the c57s who tolerate the diet very well we've also place these mice in metabolic cages and we need to analyze that data and so overall this uh Ketone Esther could be used as a treatment in as or at least with something else but overall could have efficacy in treating seizure frequency and threshold which could affect cognition in our as population so I'd like to thank my lab and committee members for their support our collabor ators Dr Di austino and Case Western Reserve University for performing the metabolic analyses and if you have any other questions other than what you have now I'm at poster A6 tonight and are there any questions I have two questions thank you this a great talk um one is um can you further elucidate on the weight loss was that despite ADB yes that was despite adlib and this is something that Angela I thought saw and there are few things that they've thought about one is increasing meano COA I believe which is an anorogenic so it's going to decrease appetite that's potential and I know um the insulin sensitivity is another potential for all of this tying into this so they it has been reported she did publish on this before she did see a decrease in in weight and in glucose so it could be power yes taste although we put some weight back up and uh we only used ideally we' want to use about 20% keton into the food but we only use 10% yeah 10 to see all these results with 10% was actually pretty small do you know what what would happen if we had 20 30 40% keeper we're not we don't it's not pable at this time uh to increase the dose and we think we might see great enhanced effects potentially and that was something I wanted to look at was food intake which is why I did the metabolic cages but you have to do with that we need to have it imp pellet form or something else because yeah it's just the mush so that's that's something I would like to look at definitely though thank you and secondly are you doing a human trial are you planning a pilot I think that's the plan okay that is the plan yes so question and comment so the only evidence you have for augmented Gaper transmission is the Gad expression right the problem with Gad expression is that it doesn't necessarily like true G levels right you have higher turnovers maybe low things like that so you so that's why we did do the gab glutamate ratio specifically in hippocampus we did do that metabolic analysis and it wasn't an overall significant increase in Gaba but again that's why we looked at the ratio but we would need more mice and have to perform more metabolic analyses we thought about doing some pulse experiments um I so I did do ppf um and I actually did not see this is suggesting that it's potentially not working by that mechanism but I do have that data and it does not seem like there's a significant difference uh in [Applause] ppf
Up Next

Taste Matters: Why We Like the Food We Do | Professor John Prescott
@smagforlivet-video
409 views•2015-12-07

How to Calculate Vmax and Km from a Lineweaver-Burk Plot
@NigelFrancis
106.4K views•2020-02-05

Enteric Nervous System Explained: The Gut's Brain | Neurobiology Lecture
@alumniu6029
438 views•2018-09-12

Bacteriophages: Earth's Deadliest Killers and Future Antibiotics
@kurzgesagt
34.6M views•2018-05-13
Related Study Plans & Knowledge Roadmaps
Structured learning paths in Biology




























![한 식단에만 매몰되면 안 되는 이유 [케톤] 2부](https://i.ytimg.com/vi/Ngbibnmuces/maxresdefault.jpg)








